您的浏览器版本太低,将不能正常浏览。请升级 Internet Explorer或使用Google Chrome浏览器。
如果您在使用双核浏览器,请切换到高速 / 极速 / 神速 核心。
Location: Home > Service-cooperation
Consistency Evaluation of Generic Pharmaceuticals and Development of Generic Pharmaceuticals for Ordinary Oral Solid Preparations

Consistency evaluation of quality and efficacy of generic drugs and R&D service of oral solid preparations are aimed at improving R&D efficiency and pass rate of one-time approval, and then improving customer satisfaction. These services mainly include analysis of characteristics of reference preparations, development of prescription technology, transfer of production technology and quality research, and declaration of CTD data. In addition, the company has established a CRO service team in cooperation with the clinical base to provide customers with all-chain services covering BE.

Development of Sustained and Controlled Release Preparations

Sustained and Controlled Release Preparations Development Services, with the R&D of Sustained and Controlled Release Preparations as the main line, has established a development team with independent intellectual property rights, core and promotional technology, mainly Indian scientists, in order to provide customers with differentiated and irreplaceable services.

Development of liquid preparations for children

In view of the shortage of children's medication market, a development platform for children's liquid preparations was established, focusing on the research and development of children's liquid preparations.

Clinical services

Regular Pharmaceutical has established cooperative relations with many domestic drug clinical trial institutions. It can manage the operation of the project precisely according to the relevant regulations of ICH, FDA and SFDA. Through high-quality and efficient professional services, it can reduce the cost of R&D for customers and shorten the time of R&D.

CONTACT
CMC Service Manager Yan 86-132-8008-6176
Email:yanyali@hq-pharma.com
Clinical Services Manager Li 86-132-80640-394
Email:liminmin@hq-pharma.com
HR Ms.Kong
86-183-6997-3236(Zibo)
Ms.Wu
86-153-0177-9963(Shanghai)
Email:hr@hq-pharma.com